tirzepatide new england journal of medicine In the SURMOUNT-1 trial (published in NEJM in July 2022) in participants with #obesity, 5 mg, 10 mg, or 15 mg once weekly provided substantial and sustained reductions in body weight. SURMOUNT-1 Trial - Cardionerds Twitter
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13















:max_bytes(150000):strip_icc()/VWH-GettyImages-1445262043-303759cd66f04a9e8a3073a0d05a8c54.jpg)











